Effects of Microcrystalline Titanium Dioxide With Covalently Linked Monovalent Silver Ions on Complications After Total Hysterectomy
Maneno muhimu
Kikemikali
Tarehe
Imethibitishwa Mwisho: | 11/30/2018 |
Iliyowasilishwa Kwanza: | 12/26/2018 |
Uandikishaji uliokadiriwa Uliwasilishwa: | 12/27/2018 |
Iliyotumwa Kwanza: | 12/30/2018 |
Sasisho la Mwisho Liliwasilishwa: | 12/27/2018 |
Sasisho la Mwisho Lilichapishwa: | 12/30/2018 |
Tarehe halisi ya kuanza kwa masomo: | 12/31/2018 |
Tarehe ya Kukamilisha Msingi iliyokadiriwa: | 06/29/2019 |
Tarehe ya Kukamilisha Utafiti: | 12/30/2019 |
Hali au ugonjwa
Uingiliaji / matibabu
Other: TIAB treatment
Other: Placebo
Awamu
Vikundi vya Arm
Mkono | Uingiliaji / matibabu |
---|---|
Experimental: TIAB treatment From the first postoperative day for ten days, single vaginal capsule per day of TIAB (microcrystalline titanium dioxide with covalently linked monovalent silver ions), Sodium Hyaluronate, and Aloe Barbadensis Extract vaginal capsule. | Other: TIAB treatment TIAGIN vaginal capsule, composition: TIAB (microcrystalline titanium dioxide with covalently linked monovalent silver ions), Sodium Hyaluronate, Aloe Barbadensis Extract |
Placebo Comparator: Placebo From the first postoperative day for ten days, single vaginal capsule per day of sodium Hyaluronate, and Aloe Barbadensis Extract vaginal capsule. | Other: Placebo Placebo vaginal capsule, composition: Sodium Hyaluronate, Aloe Barbadensis Extract |
Vigezo vya Kustahiki
Zama zinazostahiki Kujifunza | 18 Years Kwa 18 Years |
Jinsia Inastahiki Kujifunza | Female |
Hupokea Wajitolea wa Afya | Ndio |
Vigezo | Inclusion Criteria: - Women underwent laparoscopic total hysterectomy for benign gynecological pathology Exclusion Criteria: - Women underwent non-laparoscopic total hysterectomy - Women underwent laparoscopic total hysterectomy for malignant pathology - Patients with diabetes mellitus in insulin therapy - Smoking patients - Patients suffering from chronic rheumatic diseases or chronic diseases not in adequate control. |
Matokeo
Hatua za Matokeo ya Msingi
1. Vaginal bleeding [Between the 10th post operative day and the 30th post operative day]
2. Vaginal vault infection [Between the first post operative day and the 30th post operative day]
3. Urinary tract infection [Between the 10th post operative day and the 30th post operative day]
4. Dehiscence of vaginal vault suture [Between the 10th post operative day and the 30th post operative day]
5. Readmission [Between the day of discharge and the 30th post operative day]
Hatua za Matokeo ya Sekondari
1. Adverse events [Between the first post operative day and the 30th post operative day]